CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy
出版年份 2012 全文链接
标题
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 14, Issue 1, Pages 47-62
出版商
Future Medicine Ltd
发表日期
2012-12-20
DOI
10.2217/pgs.12.187
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo
- (2012) Kathrin Klein et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures andin silicomodeling
- (2012) Dong Dong et al. DRUG METABOLISM REVIEWS
- The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients
- (2012) Laure Elens et al. Pharmacogenetics and Genomics
- Validation of tacrolimus equation to predict troughs using genetic and clinical factors
- (2012) Chaitali Passey et al. PHARMACOGENOMICS
- Dosing equation for tacrolimus using genetic variants and clinical factors
- (2011) Chaitali Passey et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetic biomarkers: cytochrome P450 3A5
- (2011) Iain A.M. MacPhee CLINICA CHIMICA ACTA
- A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients
- (2011) L. Elens et al. CLINICAL CHEMISTRY
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Analysis of CYP3A4 genetic polymorphisms in Han Chinese
- (2011) Qing Zhou et al. JOURNAL OF HUMAN GENETICS
- Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study
- (2011) Laure Elens et al. Pharmacogenetics and Genomics
- Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients
- (2011) Laure Elens et al. PHARMACOGENOMICS
- Genotypes and phenotypes of CYP3A in Bangladeshi population
- (2010) Abdullah Al Maruf et al. CLINICA CHIMICA ACTA
- Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
- (2010) Christine E. Staatz et al. CLINICAL PHARMACOKINETICS
- Effects of the CYP3A5*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysis
- (2010) Hui-Lin Tang et al. Pharmacogenetics and Genomics
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects
- (2009) Yong Zeng et al. ACTA PHARMACOLOGICA SINICA
- Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
- (2009) Pierre Wallemacq et al. THERAPEUTIC DRUG MONITORING
- The CYP3A4*18 Genotype in the Cytochrome P450 3A4 Gene, a Rapid Metabolizer of Sex Steroids, Is Associated With Low Bone Mineral Density
- (2008) YS Kang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Influence of CYP3A5 Genotype on Dexamethasone Induction of CYP3A Activity in African Americans
- (2008) P. J. Roberts et al. DRUG METABOLISM AND DISPOSITION
- Defective Activity of Recombinant Cytochromes P450 3A4.2 and 3A4.16 in Oxidation of Midazolam, Nifedipine, and Testosterone
- (2008) M. Miyazaki et al. DRUG METABOLISM AND DISPOSITION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started